Curtis, E. M. et al. Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status. Bone 87, 19–26 (2016).
Article PubMed PubMed Central Google Scholar
Kanis, J. A., Melton, L. J. III, Christiansen, C., Johnston, C. C. & Khaltaev, N. The diagnosis of osteoporosis. J. Bone Min. Res. 9, 1137–1141 (1994).
Orwoll, E. S. & Bliziotes, M. Heterogeneity in osteoporosis. Men versus women. Rheum. Dis. Clin. North. Am. 20, 671–689 (1994).
Article CAS PubMed Google Scholar
Rinonapoli, G. et al. Osteoporosis in men: a review of an underestimated bone condition. Int. J. Mol. Sci. 22, https://doi.org/10.3390/ijms22042105 (2021).
Kanis, J. A. et al. Long-term risk of osteoporotic fracture in Malmö. Osteoporos. Int. 11, 669–674 (2000).
Article CAS PubMed Google Scholar
Melton, L. J. III, Atkinson, E. J., O’Connor, M. K., O’Fallon, W. M. & Riggs, B. L. Bone density and fracture risk in men. J. Bone Min. Res. 13, 1915–1923 (1998).
Gullberg, B., Johnell, O. & Kanis, J. A. World-wide projections for hip fracture. Osteoporos. Int. 7, 407–413 (1997).
Article CAS PubMed Google Scholar
Kannegaard, P. N., van der Mark, S., Eiken, P. & Abrahamsen, B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 39, 203–209 (2010).
Borgström, F. et al. Fragility fractures in Europe: burden, management and opportunities. Arch. Osteoporos. 15, 59 (2020).
Article PubMed PubMed Central Google Scholar
Chang, K. P., Center, J. R., Nguyen, T. V. & Eisman, J. A. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo osteoporosis epidemiology study. J. Bone Min. Res. 19, 532–536 (2004).
Hernlund, E. et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch. Osteoporos. 8, 136 (2013).
Article CAS PubMed PubMed Central Google Scholar
Wehren, L. E. et al. Gender differences in mortality after hip fracture: the role of infection. J. Bone Min. Res. 18, 2231–2237 (2003).
Jiang, H. X. et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J. Bone Min. Res. 20, 494–500 (2005).
Katsoulis, M. et al. Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J. Intern. Med. 281, 300–310 (2017).
Article CAS PubMed Google Scholar
Shanbhogue, V. V., Brixen, K. & Hansen, S. Age- and sex-related changes in bone microarchitecture and estimated strength: a three-year prospective study using HRpQCT. J. Bone Min. Res. 31, 1541–1549 (2016).
Wagner, P., Chapurlat, R., Ecochard, R. & Szulc, P. Low muscle strength and mass is associated with the accelerated decline of bone microarchitecture at the distal radius in older men: the prospective STRAMBO study. J. Bone Min. Res. 33, 1630–1640 (2018).
Seeman, E. The growth and age-related origins of bone fragility in men. Calcif. Tissue Int. 75, 100–109 (2004).
Article CAS PubMed Google Scholar
Seeman, E. et al. Osteoporosis in men–consensus is premature. Calcif. Tissue Int. 75, 120–122 (2004).
Article CAS PubMed Google Scholar
Chaitou, A. et al. Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study. J. Bone Min. Res. 25, 2313–2323 (2010).
Watts, N. B. et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 97, 1802–1822 (2012).
Article CAS PubMed Google Scholar
Bouvard, B. et al. Recommandations françaises de la prise en charge et du traitement de l’ostéoporose masculine. Rev. du Rhum. 88, 173–182 (2021).
Danish Endocrine Society. Treatment of male osteoporosis. https://endocrinology.dk/nbv/calcium-og-knoglemetabolisme/behandling-af-mandlig-osteoporose/ (2022).
Gregson, C. L. et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch. Osteoporos. 17, 58 (2022).
Article PubMed PubMed Central Google Scholar
Swedish Osteoporosis Society. Guideline. http://svos.se (2021).
DVO Dachverband Osteologie. Osteoporosis Guideline. https://www.dv-osteologie.org/ (2017).
Italian Medicines Agency. Osteoporosis Guideline. http://Aifa.gov.it (2016).
Guyatt, G. H. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br. Med. J. 336, 924–926 (2008).
Beaudart, C. et al. Efficacy of osteoporosis pharmacological treatments in men: a systematic review and meta-analysis. Aging Clin. Exp. Res. 35, 1789–1806 (2023).
Article PubMed PubMed Central Google Scholar
Honvo, G. et al. Recommendations for the reporting of harms in manuscripts on clinical trials assessing osteoarthritis drugs: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Drugs Aging 36, 145–159 (2019).
Article PubMed PubMed Central Google Scholar
World Health Organization Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. (1994).
Kanis, J. A. et al. Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos. Int. 22, 2789–2798 (2011).
Article CAS PubMed PubMed Central Google Scholar
De Laet, C. E. et al. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J. Bone Min. Res. 13, 1587–1593 (1998).
Binkley, N., Adler, R. & Bilezikian, J. P. Osteoporosis diagnosis in men: the T-score controversy revisited. Curr. Osteoporos. Rep. 12, 403–409 (2014).
Article PubMed PubMed Central Google Scholar
Kanis, J. A. et al. The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis. Osteoporos. Int. 34, 1–9 (2023).
Kanis, J. A. et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos. Int. 23, 2239–2256 (2012).
Article CAS PubMed PubMed Central Google Scholar
Kanis, J. A. et al. SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch. Osteoporos. 16, 82–82 (2021).
Article PubMed PubMed Central Google Scholar
Kanis, J. A. et al. A decade of FRAX: how has it changed the management of osteoporosis? Aging Clin. Exp. Res. 32, 187–196 (2020).
Kanis, J. A. et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos. Int. 18, 1033–1046 (2007).
Article CAS PubMed Google Scholar
Harvey, N. C. et al. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 78, 216–224 (2015).
Article CAS PubMed PubMed Central Google Scholar
McCloskey, E. V. et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J. Bone Min. Res. 31, 940–948 (2016).
Kanis, J. A., Cooper, C., Rizzoli, R. & Reginster, J. Y. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos. Int. 30, 3–44 (2019).
Article CAS PubMed Google Scholar
Kendler, D. L. et al. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391, 230–240 (2018).
Article CAS PubMed Google Scholar
Saag, K. G. et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N. Engl. J. Med. 377, 1417–1427 (2017).
Article CAS PubMed Google Scholar
Kanis, J. A. et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos. Int. 31, 1–12 (2019).
Article PubMed PubMed Central Google Scholar
Curtis, E. M. et al. Management of patients at very high risk of osteoporotic fractures through sequential treatments. Aging Clin. Exp. Res. 34, 695–714 (2022).
留言 (0)